Contributions of the PD-1/PD-L1 pathway to Borrelia persistence and inflammation

被引：0
|
作者：
Helble, Jennifer D.
McCarthy, Julie E.
Starnbach, Michael N.
Hu, Linden T.
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2022年 / 208卷 / 01期
关键词：
D O I：
10.4049/jimmunol.208.Supp.170.19
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
170.19
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
    Ewelina Grywalska
    Iwona Smarz-Widelska
    Ewelina Krasowska-Zajac
    Izabela Korona-Glowniak
    Karolina Zaluska-Patel
    Michal Mielnik
    Martyna Podgajna
    Anna Malm
    Jacek Rolinski
    Wojciech Zaluska
    Archivum Immunologiae et Therapiae Experimentalis, 2018, 66 : 133 - 143
  • [22] Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
    Kammerer-Jacquet, Solene-Florence
    Deleuze, Antoine
    Saout, Judikael
    Mathieu, Romain
    Laguerre, Brigitte
    Verhoest, Gregory
    Dugay, Frederic
    Belaud-Rotureau, Marc-Antoine
    Bensalah, Karim
    Rioux-Leclercq, Nathalie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [23] Novel, small molecule inhibitors of PD-1/PD-L1 pathway
    Rastelli, Luca
    Rajagopal, Sridharan
    Gajendran, Chandru
    Sadhu, Naveen M.
    Mohd, Zainuddin
    Gosu, Ramachandraiah
    Friedmann-Morvinski, Dinorah
    Kandan, Saravanan
    Birudukota, Swarnakumari
    Srinivasan, S.
    Krishnakumar, V
    Wahid, Saif
    Siddiqui, Amir
    Viswakarma, Santosh
    Narayan, Ashwini
    Rudresh, G.
    Mullurwar, Sadanand R.
    Sher, Divsha
    Mansur, Shahar
    Sivanandhan, Dhanalakshmi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
    Rosemarie Tremblay-LeMay
    Nasrin Rastgoo
    Hong Chang
    Journal of Hematology & Oncology, 11
  • [25] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
    Tremblay-LeMay, Rosemarie
    Rastgoo, Nasrin
    Chang, Hong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [26] Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
    Wang, Zhijie
    Yuan, Lin
    Liao, Xiaotong
    Guo, Xia
    Chen, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6027 - 6043
  • [27] Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
    Ai, Luoyan
    Xu, Antao
    Xu, Jie
    REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 : 33 - 59
  • [28] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [29] PD-1 and PD-L1 prognostic in UTUC
    Stone, Louise
    NATURE REVIEWS UROLOGY, 2017, 14 (09) : 518 - 518
  • [30] PD-1 and PD-L1 prognostic in UTUC
    Louise Stone
    Nature Reviews Urology, 2017, 14 : 518 - 518
12345